cyclothiazide has been researched along with Hypoxia-Ischemia, Brain in 1 studies
cyclothiazide: inhibits the desensitization of AMPA-type receptors; structure
cyclothiazide : 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted at positions 3, 5 and 6 by a 2-norbornen-5-yl group, chlorine, and a sulfonamide group, respectively. A thiazide diuretic, it has been used in the management of hypertension and oedema.
Hypoxia-Ischemia, Brain: A disorder characterized by a reduction of oxygen in the blood combined with reduced blood flow (ISCHEMIA) to the brain from a localized obstruction of a cerebral artery or from systemic hypoperfusion. Prolonged hypoxia-ischemia is associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; BRAIN EDEMA; COMA; and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Youssef, FF | 1 |
| Addae, JI | 1 |
| McRae, A | 1 |
| Stone, TW | 1 |
1 other study available for cyclothiazide and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Long-term potentiation protects rat hippocampal slices from the effects of acute hypoxia.
Topics: Action Potentials; Acute Disease; Animals; Benzothiadiazines; Carbon Dioxide; Cell Hypoxia; Culture | 2001 |